Albemarle Corporation (NYSE:ALB - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twenty-six ratings firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $190.0435.
A number of analysts recently weighed in on ALB shares. Morgan Stanley reiterated a "reduce" rating and issued a $161.00 price target on shares of Albemarle in a research report on Monday, August 10th. JPMorgan Chase & Co. lowered their target price on shares of Albemarle from $160.00 to $140.00 and set a "neutral" rating for the company in a research note on Tuesday, August 25th. Vertical Research upgraded shares of Albemarle from a "hold" rating to a "buy" rating and set a $224.00 target price on the stock in a report on Tuesday, May 26th. Robert W. Baird cut their target price on shares of Albemarle from $236.00 to $224.00 and set a "neutral" rating on the stock in a report on Thursday, June 18th. Finally, Mizuho reduced their price target on shares of Albemarle from $205.00 to $185.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 1st.
Read Our Latest Analysis on ALB
Albemarle Stock Down 2.8%
NYSE:ALB opened at $122.33 on Friday. The company has a quick ratio of 1.35, a current ratio of 2.09 and a debt-to-equity ratio of 0.22. Albemarle has a 12-month low of $71.25 and a 12-month high of $221.00. The stock's fifty day simple moving average is $127.41 and its 200-day simple moving average is $157.31. The firm has a market capitalization of $14.43 billion, a P/E ratio of 453.09, a P/E/G ratio of 0.74 and a beta of 1.33.
Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, beating analysts' consensus estimates of $3.20 by $0.55. Albemarle had a return on equity of 10.96% and a net margin of 3.09%.The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the prior year, the company posted $0.11 earnings per share. The firm's revenue was up 31.1% on a year-over-year basis. Equities research analysts expect that Albemarle will post 11.39 earnings per share for the current year.
Albemarle Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Friday, September 11th will be issued a dividend of $0.41 per share. This is a boost from Albemarle's previous quarterly dividend of $0.41. This represents a $1.64 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, September 11th. Albemarle's dividend payout ratio is presently 600.00%.
Institutional Investors Weigh In On Albemarle
Several large investors have recently modified their holdings of the business. Addison Advisors LLC bought a new position in shares of Albemarle during the 2nd quarter valued at about $28,000. Elyxium Wealth LLC bought a new stake in Albemarle during the 4th quarter worth approximately $34,000. Sound Income Strategies LLC raised its holdings in Albemarle by 190.1% during the 1st quarter. Sound Income Strategies LLC now owns 293 shares of the specialty chemicals company's stock worth $52,000 after buying an additional 192 shares during the period. Root Financial Partners LLC raised its holdings in Albemarle by 121.5% during the 4th quarter. Root Financial Partners LLC now owns 299 shares of the specialty chemicals company's stock worth $42,000 after buying an additional 164 shares during the period. Finally, Dakota Community Bank & Trust NA bought a new position in Albemarle in the first quarter valued at approximately $54,000. 92.87% of the stock is currently owned by institutional investors.
Albemarle Company Profile
(
Get Free Report)
Albemarle Corporation NYSE: ALB is a global specialty chemicals company that develops, manufactures and markets products used in energy storage, transportation, electronics, construction, agriculture, pharmaceuticals and other industrial applications. The company operates through three principal businesses: Energy Storage, Specialties and Ketjen.
Albemarle is one of the major producers of lithium and lithium compounds, including lithium carbonate and lithium hydroxide, which are used in rechargeable batteries for electric vehicles, portable electronics and stationary energy storage systems.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.